Recombinant Zika Capsid (Uganda) [His]

Product Overview

C-terminal 6xHis tagged Capsid (Zika/Uganda) protein (a.a. 1-125) (GenBank Accession No. YP_002790881).

Nature

Recombinant

Tag/Conjugate

His

Alternative Names

Zika virus; ZIKV; Zika virus Capsid; ZIKV Capsid; Zika virus Capsid protein; Flaviviridae; Flavivirus

Purity

>90%, based on SDS PAGE

Format

Liquid

Concentration

Batch dependent - please inquire should you have specific requirements.

Buffer

Each vial contains 100 μg of protein in PBS with 8M Urea.

Preservative

None

Storage

Keep it at 4°C if used within a month. For long term storage, split it into small aliquots and keep at -80℃. Avoid repeated freezing and thawing. The product will be expired one year after receiving if stored properly.

Antigen Description

Zika virus is an emerging disease that is spread by Aedes mosquitoes. The virus was first isolated in Central Africa, and has since been spread to South Asia and recently to South America. Zika virus can cause mild fever, rash, myalgia, arthralgia and headaches, with one in four infected individuals being asymptomatic. Due to similar symptoms Zika virus infected individuals can easily be mis-diagnosed as a dengue infection and vice-versa. In addition, Zika virus has been implicated in causing microcephaly through transmission in utero.

Keywords

Zika virus; ZIKV; Zika virus Capsid; ZIKV Capsid; Zika virus Capsid protein; Flaviviridae; Flavivirus